Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

10
Number of overlapping holdings
43.5%
% of PPH's 26 holdings also in XLV
16.4%
% of XLV's 61 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus XLV)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PPH |
Weight in XLV |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 13.5% | 12.3% | 12.3% | |
JOHNSON & JOHNSON | 7.4% | 7.4% | 7.4% | |
ABBVIE INC | 7.5% | 6.9% | 6.9% | |
MERCK & CO. INC. | 4.7% | 4.4% | 4.4% | |
PFIZER INC | 4.5% | 2.8% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to XLV
NOVO-NORDISK A/S-SPONS ADR | 5.6% | |
NOVARTIS AG-ADR | 5.5% | |
ASTRAZENECA PLC-SPONS ADR | 5.4% | |
SANOFI-AVENTIS-ADR | 5.2% | |
GLAXOSMITHKLINE PLC-SPON ADR | 5.0% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.9% | |
CENCORA INC | 4.2% | |
MCKESSON CORP | 3.4% | |
TEVA PHARMACEUTICAL-SP ADR | 2.9% | |
ZOETIS INC | 2.6% |
PPH Underweight Relative to XLV
UNITEDHEALTH GROUP INC | -8.9% | |
ABBOTT LABORATORIES | -4.1% | |
THERMO FISHER SCIENTIFIC INC | -3.7% | |
INTUITIVE SURGICAL INC | -3.3% | |
AMGEN INC | -3.2% | |
BOSTON SCIENTIFIC CORP | -2.8% | |
DANAHER CORP | -2.5% | |
GILEAD SCIENCES INC | -2.5% | |
VERTEX PHARMACEUTICALS INC | -2.4% | |
STRYKER CORP | -2.4% |